V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10451501 | 10034258 | 1.76 | 70.7 | 03 | null | 2021-01-24 | Capecitabine + Oxaliplatin 21day | N | N | PEMBROLIZUMAB | 100602292 |
| 10451511 | 10034259 | 1.6 | 115 | Adjuvant (A) | 2019-01-01 | 2019-01-13 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE | 100590142 |
| 10451537 | 10034260 | 1.74 | 74.5 | null | 2021-05-21 | 2021-06-11 | CAPECITABINE + OXALIPLATIN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101636693 |
| 10451583 | 10034261 | 1.55 | 66.9 | Palliative (P) | 2017-09-10 | 2017-09-21 | Rituximab | 2 | N | RITUXIMAB | 100743511 |
| 10451585 | 10034262 | 1.54 | 78 | null | 2019-07-01 | 2019-07-01 | Rituximab | 02 | null | RITUXIMAB | 100448020 |
| 10451628 | 10034263 | 1.64 | 62.1 | 03 | 2017-04-29 | 2017-05-14 | Capecitabine + Oxaliplatin 14day | 02 | N | CAPECITABINE | 101459943 |
| 10451660 | 10034264 | 1.75 | 110 | Neo-adjuvant (N) | 2020-01-02 | 2020-01-02 | IBRUTINIB | 02 | null | IBRUTINIB | 100546585 |
| 10451697 | 10034265 | 1.55 | 60 | Adjuvant (A) | 2019-04-16 | 2019-04-16 | IBRUTINIB | 02 | N | IBRUTINIB | 100735448 |
| 10451718 | 10034266 | 1.8 | 79 | Curative (C) | 2017-10-25 | 2017-10-27 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101032921 |
| 10451721 | 10034267 | 1.7 | 70.5 | Palliative (P) | 2017-10-31 | 2017-11-13 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101021932 |
| 10451773 | 10034268 | 1.74 | 89 | Palliative (P) | 2017-05-12 | 2017-05-19 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101412218 |
| 10451776 | 10034269 | 1.73 | 67.7 | Neo-adjuvant (N) | 2016-05-28 | 2016-05-29 | Docetaxel | 2 | null | DOCETAXEL | 100845689 |
| 10451829 | 10034270 | 1.82 | 80.4 | null | 2018-05-28 | 2018-05-28 | CAPECITABINE + RT | 02 | null | CAPECITABINE | 100096639 |
| 10451850 | 10034271 | 1.62 | 66.95 | Palliative (P) | 2021-02-24 | 2021-02-24 | PEMBROLIZUMAB | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100458738 |
| 10451851 | 10034272 | 1.85 | 111.9 | null | 2020-10-12 | 2020-10-22 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100509856 |
| 10451856 | 10034273 | null | 104.9 | Adjuvant (A) | 2017-08-13 | 2017-08-22 | Rituximab | 02 | N | RITUXIMAB | 101152015 |
| 10451866 | 10034274 | 1.74 | 68.4 | Adjuvant (A) | 2021-08-23 | 2021-08-29 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101683681 |
| 10451877 | 10034275 | 1.66 | 67.8 | null | null | 2020-09-05 | Capecitabine | 02 | null | CAPECITABINE | 101545776 |
| 10451883 | 10034276 | 1.73 | 67 | Palliative (P) | null | 2021-01-11 | Docetaxel | 02 | N | DOCETAXEL | 100958077 |
| 10451891 | 10034277 | null | 76.2 | 03 | 2020-05-08 | 2020-05-29 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100827507 |
| 10451898 | 10034278 | 1.65 | 42 | 03 | 2018-11-04 | 2018-11-23 | Docetaxel | 02 | N | DOCETAXEL | 100295811 |
| 10451903 | 10034279 | 1.68 | 75.6 | Curative (C) | 2017-02-06 | 2017-02-20 | Capecitabine | 02 | N | CAPECITABINE | 100092407 |
| 10451908 | 10034280 | 1.63 | 85 | null | 2022-01-13 | 2022-01-14 | CAPECITABINE + OXALIPLATIN | 02 | null | IBRUTINIB | 100966177 |
| 10451919 | 10034281 | 1.77 | 96.1 | 03 | 2015-10-28 | 2015-11-17 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100405957 |
| 10451924 | 10034282 | 1.7 | 70.5 | Palliative (P) | 2020-06-23 | 2020-07-24 | IBRUTINIB | 02 | N | IBRUTINIB | 100852301 |
| 10451947 | 10034283 | 1.66 | 97 | Palliative (P) | 2016-10-27 | 2016-12-28 | PEMBROLIZUMAB | N | N | PEMBROLIZUMAB | 101606550 |
| 10451960 | 10034284 | 1.82 | 55 | Curative (C) | null | 2017-12-10 | Capecitabine + Oxaliplatin 21day | 02 | N | IBRUTINIB | 100535639 |
| 10451994 | 10034285 | 1.64 | 63 | Disease modification (D) | 2018-09-01 | 2018-09-03 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100421272 |
| 10451996 | 10034286 | 1.62 | 51.7 | Palliative (P) | 2019-03-09 | 2019-04-30 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 101052960 |
| 10452026 | 10034287 | null | 57.7 | Curative (C) | 2019-03-12 | 2019-03-14 | Capecitabine | 02 | N | CAPECITABINE | 100358392 |
| 10452087 | 10034288 | 1.7 | 82.6 | Palliative (P) | 2021-09-05 | 2021-09-15 | Capecitabine + Oxaliplatin 14day | 02 | N | CAPECITABINE + OXALIPLATIN | 101722157 |
| 10452090 | 10034289 | 1.79 | 63.8 | Palliative (P) | 2016-08-06 | 2016-08-30 | Rituximab | 02 | Y | RITUXIMAB | 101530765 |
| 10452096 | 10034290 | 1.67 | 58.7 | Disease modification (D) | 2016-07-18 | 2016-08-01 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 101471024 |
| 10452099 | 10034291 | 0 | 64 | Curative (C) | 2018-12-21 | 2018-12-28 | CHOP R - 21 days | 02 | N | PEMBROLIZUMAB | 100669816 |
| 10452130 | 10034292 | 1.75 | 64.2 | Palliative (P) | 2014-10-26 | 2014-11-10 | Capecitabine + Oxaliplatin 21day | 02 | N | RITUXIMAB | 101019098 |
| 10452138 | 10034293 | 1.93 | 78.7 | Neo-adjuvant (N) | 2021-08-22 | 2021-08-24 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101232992 |
| 10452150 | 10034294 | 1.82 | 86 | Adjuvant (A) | 2017-05-31 | 2017-05-31 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101055370 |
| 10452155 | 10034295 | 1.8 | 107 | Neo-adjuvant (N) | 2019-01-24 | 2019-01-31 | CAPECITABINE + OXALIPLATIN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101429753 |
| 10452160 | 10034296 | 1.8 | 76.65 | Neo-adjuvant (N) | 2019-05-23 | 2019-05-31 | CAPECITABINE + OXALIPLATIN | 02 | null | PEMBROLIZUMAB | 101634125 |
| 10452193 | 10034297 | 1.71 | 70.4 | 03 | 2018-07-08 | 2019-03-24 | Rituximab | 02 | N | RITUXIMAB | 101138981 |
| 10452196 | 10034298 | 1.83 | 96.6 | 03 | 2021-04-10 | 2021-04-17 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 100433713 |
| 10452197 | 10034299 | 1.79 | 82 | Curative (C) | 2017-06-25 | 2017-06-30 | Capecitabine | 02 | null | CAPECITABINE | 100012881 |
| 10452212 | 10034301 | 1.79 | 85.8 | Neo-adjuvant (N) | 2019-10-11 | 2019-10-19 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100331007 |
| 10452233 | 10034302 | null | null | null | 2022-03-12 | 2022-03-12 | IBRUTINIB | 02 | null | IBRUTINIB | 100647249 |
| 10452253 | 10034303 | 1.57 | 72.3 | 03 | null | 2019-09-26 | Capecitabine | 02 | N | CAPECITABINE | 101731959 |
| 10452267 | 10034304 | 1.74 | 64.2 | null | 2018-08-01 | 2018-08-06 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100603049 |
| 10452276 | 10034305 | 1.65 | 120 | null | 2021-11-28 | 2021-11-29 | IBRUTINIB | 02 | null | IBRUTINIB | 101003069 |
| 10452307 | 10034306 | 1.61 | 58.2 | Palliative (P) | 2015-07-13 | 2015-07-21 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100372688 |
| 10452332 | 10034307 | 1.69 | 69.45 | 03 | null | 2017-02-02 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100245331 |
| 10452353 | 10034308 | 1.47 | 45.95 | Neo-adjuvant (N) | 2018-09-30 | 2018-10-22 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100916856 |